<DOC>
	<DOCNO>NCT00904566</DOCNO>
	<brief_summary>By use gene-expression profiling , Va n't Veer colleague develop 70-gene prognosis profile , MammaPrint , identify breast cancer patient low risk develop distant metastasis therefore might safely spar chemotherapy . The aim study evaluate prognostic value 70-gene Mammaprint profile Japanese woman node-negative breast cancer .</brief_summary>
	<brief_title>Validation 70-gene MammaPrint Profile Japanese Population</brief_title>
	<detailed_description>Frozen tumor sample 140 node-negative , breast cancer patient age 29 70 year diagnosis hybridize MammaPrint array . Patients treat breast conserve therapy mastectomy axillary lymph node dissection December 1998 August 2001 Osaka Medical Center Cancer Cardiovascular Diseases . Samples evaluate gene expression profile 70-gene MammaPrint profile classify genomic high risk genomic low risk .</detailed_description>
	<criteria>Breast cancer patient Nodenegative Treated breast conserve therapy mastectomy axillary lymph node dissection Osaka Medical Center Cancer Cardiovascular Diseases</criteria>
	<gender>Female</gender>
	<minimum_age>29 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>microarray</keyword>
	<keyword>gene expression profile</keyword>
	<keyword>MammaPrint</keyword>
	<keyword>breast cancer</keyword>
</DOC>